SCHEMBL31455640 — predicted protein targets

Predicted protein targets (top 16)

	gene	UniProt	supporting neighbours	confidence
▸	PTGS1	P23219	1/20	0.38

▸	PTGS2	P35354	1/20	0.38

▸	KMT2A	Q03164	2/20	0.37

▸	MEN1	O00255	1/20	0.37

▸	CES2	O00748	1/20	0.35

▸	CES1	P23141	1/20	0.35

▸	TAS1R3	Q7RTX0	1/20	0.34

▸	TAS1R1	Q7RTX1	1/20	0.34

▸	ALDH1A1	P00352	2/20	0.33

▸	POLB	P06746	1/20	0.33

▸	HPGD	P15428	1/20	0.33

▸	NPC1	O15118	1/20	0.33

▸	CYP1A2	P05177	1/20	0.33

▸	CYP2C19	P33261	1/20	0.33

▸	RAB9A	P51151	1/20	0.33

▸	SMN1; SMN2	Q16637	1/20	0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31494830	0.81	CES2 (0.47)	PTGS1PTGS2KMT2AMEN1CES2
SCHEMBL10773337	0.77	PTGS1 (0.40)	PTGS1PTGS2KMT2AMEN1ALDH1A1
SCHEMBL31455895	0.77	PTGS1 (0.40)	PTGS1PTGS2KMT2AMEN1ALDH1A1
SCHEMBL8676087	0.76	KMT2A (0.50)	PTGS1PTGS2KMT2AMEN1CES2
SCHEMBL8472060	0.76	KMT2A (0.50)	PTGS1PTGS2KMT2AMEN1CES2
SCHEMBL31612953	0.76	KMT2A (0.50)	PTGS1PTGS2KMT2AMEN1CES2
SCHEMBL31455566	0.76	PTGS1 (0.42)	PTGS1PTGS2KMT2AMEN1CES2
SCHEMBL2871090	0.76	ANPEP (0.42)	PTGS1ALDH1A1HPGDCYP1A2
SCHEMBL23270664	0.75	CES2 (0.42)	KMT2AMEN1CES2CES1ALDH1A1
SCHEMBL29907852	0.75	CES2 (0.42)	KMT2AMEN1CES2CES1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2025059562-A1	SUBSTITUTED AMINOPYRIDINE COMPOUNDS AND METHODS OF TREATING DISEASE USING SAME	ATAVISTIK BIO, INC. (US)	2025-03-20	—	—	WO	disclosed